PharmGen Science Inc (004720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, PharmGen Science Inc (004720) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.91 Billion ≈ $1.29 Million USD) by net assets (₩247.76 Billion ≈ $167.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PharmGen Science Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how PharmGen Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does PharmGen Science Inc carry for a breakdown of total debt and financial obligations.

PharmGen Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmGen Science Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lument Finance Trust Inc NYSE:LFT	0.005x
Hydrogene De France SA PA:HDF	-0.075x
Global Fashion Group S.A F:GFG	-0.222x
THINKWARE Corporation KQ:084730	0.070x
5E Advanced Materials Inc NASDAQ:FEAM	-0.101x
Kerjaya Prospek Property Bhd KLSE:7077	0.050x
Heidmar Maritime Holdings Corp. Common Stock NYSE:HMR	-0.322x
RTG Mining Inc TO:RTG	0.000x

Annual Cash Flow Conversion Efficiency for PharmGen Science Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of PharmGen Science Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see PharmGen Science Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩249.43 Billion ≈ $169.03 Million	₩2.38 Billion ≈ $1.62 Million	0.010x	-59.89%
2023-12-31	₩228.21 Billion ≈ $154.66 Million	₩5.44 Billion ≈ $3.69 Million	0.024x	+483.79%
2022-12-31	₩207.12 Billion ≈ $140.36 Million	₩-1.29 Billion ≈ $-871.62K	-0.006x	-110.13%
2021-12-31	₩126.93 Billion ≈ $86.02 Million	₩7.78 Billion ≈ $5.28 Million	0.061x	+91.54%
2020-12-31	₩83.57 Billion ≈ $56.63 Million	₩2.68 Billion ≈ $1.81 Million	0.032x	-28.64%
2019-12-31	₩56.25 Billion ≈ $38.12 Million	₩2.52 Billion ≈ $1.71 Million	0.045x	-39.50%
2018-12-31	₩56.85 Billion ≈ $38.52 Million	₩4.22 Billion ≈ $2.86 Million	0.074x	+106.01%
2017-12-31	₩51.05 Billion ≈ $34.60 Million	₩1.84 Billion ≈ $1.25 Million	0.036x	-83.10%
2016-12-31	₩36.41 Billion ≈ $24.67 Million	₩7.75 Billion ≈ $5.26 Million	0.213x	+68.55%
2015-12-31	₩28.66 Billion ≈ $19.42 Million	₩3.62 Billion ≈ $2.45 Million	0.126x	+226.04%
2014-12-31	₩20.12 Billion ≈ $13.63 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.100x	+43.17%
2013-12-31	₩23.83 Billion ≈ $16.15 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.176x	-213.97%
2011-12-31	₩18.69 Billion ≈ $12.67 Million	₩2.89 Billion ≈ $1.96 Million	0.155x	--

About PharmGen Science Inc

KO:004720 Korea Drug Manufacturers - General

Market Cap

$62.30 Million

₩91.92 Billion KRW

Market Cap Rank

#21028 Global

#1309 in Korea

Share Price

₩4195.00

Change (1 day)

+0.48%

52-Week Range

₩3500.00 - ₩4925.00

All Time High

₩27300.00